ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice. (2017)
Attributed to:
Tropical Infectious Disease Consortium: Sustaining, Expanding and Accelerating Product Development
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2017.05.032
PubMed Identifier: 28579232
Publication URI: http://europepmc.org/abstract/MED/28579232
Type: Journal Article/Review
Volume: 35
Parent Publication: Vaccine
Issue: 30
ISSN: 0264-410X